Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?

Molecular Biology Reports

Volumn 38, Issue 4, 2011, Pages 2569-2572

  Urhan Kucuk, M ^a,e   Erdal, M E ^a   Ozen, M E ^b   Kul, S ^c   Herken, H ^d  

^a MERSIN UNIVERSITY   (Turkey)

^b Nobel Medicine Centre   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

^d PAMUKKALE UNIVERSITY   (Turkey)

^e ADIYAMAN UNIVERSITY   (Turkey)

Author keywords

DRD3 mRNA; PBL; RT PCR; Schizophrenia

Indexed keywords

DOPAMINE 3 RECEPTOR; MESSENGER RNA; DIAGNOSTIC AGENT; PRIMER DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; SCHIZOPHRENIA; CLASSIFICATION; GENETICS; METABOLISM; NONPARAMETRIC TEST;

DNA PRIMERS; HUMANS; LYMPHOCYTES; RECEPTORS, DOPAMINE D3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 79960956501     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0396-4     Document Type: Article

References (23)

1. Barbanti P, Fabbrini G, Ricci A, Paola Pascali M, Bronzetti E, Amenta F et al (2000) Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 20:15-19
2. Chen CH, Liu MY, Wei FC, Koong FJ, Hwu H-G, Hsiao KJ (1997) Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene schizophrenia. Am J Med Genet 74:40-43
3. Muglia P, Jain U, Kennedy JL (2002) A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder. Behav Brain Res 130:91-95
4. Rocca P, De Leoa C, Evab C, Marchiaroa L, MIlania AM, Mussoa R et al (2002) Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 26:1155-1160
5. Sivagnanasundaram S, Morrisa AG, Gaitonde EJ, McKenna PJ, Mollon JD, Hunt DM (2000) A cluster of single nucleotide polymorphisms in the 50-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia. Neurosci Lett 279:13-16
6. Ohara K, Nagai M, Tani K, Nakamura Y, Ino A, Ohara K (1998) Functional polymorphism of-141 ins/del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81:117-123
7. Amenta F, Ricci A, Tayebati SK, Zaccheo D (2002) The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 107(3):145-167
8. Czermak C, Lehofer M, Renger H, Wagner EM, Lemonis L, Rohrhofer A et al (2004) Dopamine receptor D3 mRNA expression in human lymphocytes is negatively correlated with the personality trait of persistence. J Neuroimmunol 150:145-149
9. Staddon S, Arranza MJ, Mancama D, Perez-Nievas F, Arrizabalaga I, Anney R, Buckland P, Elkina A, Osborne S, Munro J, Mata I, Kerwina RW (2004) Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophr Res 96:51-57
10. Hartman DS, Civelli O (1996) Molecular attributes of dopamine receptors: new potential for antipsychotic drug development. Ann Med 28(3):211-219
11. Kwak YT, Koo MS, Choi CH, Sunwoo IN (2001) Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med Genet 2(3):471-478
12. Laurance DR, Bennet PN, Brown MJ (1997) Clinical pharmacology, 8th edn. Toronto, pp 230-232
13. Tarazi FI (2001) Neuoro pharmacology of dopamine receptors: implications in neuropsychiatric diseases. Med Sci 3(2):87-104
14. Eichhammer P, Albus M, Borrmann-Hassebach M, Schoeler A, Putzhammer A, Frick U, Klein HE et al (2000) Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia. Am J Med Genet 96:187-191
15. Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, Aschauer HN, McCreadie RG, Ohlraun S, Ferrier N, Masellis M, Verga M, Scharfetter J, Rietschel M, Lovlie R, Levy UH, Meltzer HY (2002) Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly. polymorphism. Neuropsychopharmacology 27(1):34-39
16. Levant B (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49(3):231-252
17. Woo SI, Kim JW, Rha E, Han SH, Hahn KH, Park CS et al (2002) Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean. Schizophrenics Psychiatry Clin Neurosci 56:469-474
18. Ilani T, Ben-Shachar D, Strous RD, Mazor M, Sheinkman A, Kotler M et al (2001) A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. PNAS 98(2):625-628
19. Czermak C, Lehofer M, Wagner EM, Prietl B, Lemonis L, Rohrhofer A et al (2004) Reduced dopamine D4 receptor mRNA expression in lymphocytes of long-term abstinent alcohol and heroin addicts. Soc Study Addict 99:251-257. doi:10.1080/14622 200310001656858
20. Ricci A, Bronzetti E, Mignini F, Tayebati SK, Zaccheo D, Amenta F (1999) Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 96:234-240
21. Vogel M, Pfeifer S, Schaub RT, Grabe H-J, Barnowa V, Freybergera HJ et al (2004) Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients. Neuropsychobiology 50:305-310. doi:10.1159/000080958
22. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
23. Van Der Weide J, Steijin LSW, Van Der Geld M, De Groot PA (2003) D3 dopamine receptor mRNA expression in lymphocytes: a peripheral marker for schzophrenia? Acta Neuropyschiatrica 15:91-93